Example: stock market
MODULE 2.4 NONCLINICAL OVERVIEW
CONFIDENTIAL m2.4. Nonclinical Overview 2012N153960_00 7 1. OVERVIEW OF THE NONCLINICAL TESTING STRATEGY 1.1. Introduction Dolutegravir is a novel, potent and selective orally bioavailable integrase inhibitor.
Tags:
Information
Domain:
Source:
Link to this page:
Documents from same domain
339 - pmda.go.jp
www.pmda.go.jp医薬品・医療機器等安全性情報 No.339 −3− 2016年12月 1 ミルナシプラン塩酸塩，デュロキセチン塩酸塩 及びベンラファキシン塩酸塩製剤の自動車運転等
Report on the Deliberation Results - pmda.go.jp
www.pmda.go.jpReport on the Deliberation Results . December 3, 2014 . Evaluation and Licensing Division, Pharmaceutical and Food Safety Bureau . Ministry of Health, Labour and Welfare
Filgrastim, Lenograstim, Nartograstim, Pegfilgrastim
www.pmda.go.jpPharmaceuticals and Medical Devices Agency This English version is intended to be a reference material for the convenience of users. In the event of
Pharmaceuticals and Medical Devices Safety …
www.pmda.go.jpPharmaceuticals and Medical Devices Safety Information No. 347 - 3 - October 2017 Abbreviations ADR Adverse drug reaction Alb Albumin ALP Alkaline phosphatase
The Ministry of Health, Labour and Welfare …
www.pmda.go.jpThe Ministry of Health, Labour and Welfare Ministerial Notification No. 519 Pursuant to Paragraph 1, Article 41 of the Pharmaceutical AŠairs Law (Law No.
2018.3 No. 267 - pmda.go.jp
www.pmda.go.jp1 2018. 3. dsu no. 267 重 要 生薬 510 サンシシ 2 漢方製剤 520 茵蔯蒿湯 3 温清飲 4 黄連解毒湯 3 加味帰脾湯 4
PMDA HP
www.pmda.go.jp後発医薬品品質情報 no.9 4 独立行政法人医薬品医療機器総合機構（pmda）では、本誌情報やジェネリック医薬品品質情報検討会の
PMDAからの医薬品適正使用のお願い - pmda.go.jp
www.pmda.go.jp医薬品医療機器総合機構PMDA. からの医薬品適正使用のお願い http://www.pmda.go.jp/safety/info-services/drugs/0001.html
IMPURITIES GUIDELINE FOR RESIDUAL S Q3C(R5)
www.pmda.go.jpinternational conference on harmonisation of technical requirements for registration of pharmaceuticals for human use ich harmonised tripartite guideline impurities: guideline for …
2.7.2 summary of clinical pharmacology Studies
www.pmda.go.jpCONFIDENTIAL RM2003/00379/00 2.7.2 Summary of Clinical Pharmacology 4 ABBREVIATIONS 3TC lamivudine (EPIVIRƒ) ABC abacavir (ZIAGENƒ)AE Adverse Event AUC0-t,ss Area under the drug concentration-time curve from 0 to time t at steady state AUC∞ Area under the plasma concentration versus time curve from time 0 and …
Related documents
AdEasy Adenoviral Vector System - Agilent
www.agilent.comAdEasy Adenoviral Vector System 3 INTRODUCTION Recombinant adenoviruses are a versatile tool for gene delivery and expression. Several features of adenovirus biology have made such viruses
Antonio Alcami and Ulrich H. Koszinowski
www.ncf-net.orgiruses must be extremely suc-cessful predators as they de-pend on living cells for repli-cation. Almost all living species represent prey for a viral invader.
Understanding Viruses, Third Edition
samples.jbpub.com© Jones & Bartlett Learning, 2017 ontact Your Publishers Representative For More Information 1-800-832-0034 • info@jblearning.com • www.jblearning.com
THE RESPIRATORY VIRUSES: INFLUENZA, RSV, AND …
www.columbia.eduMID 32 C. Mhorag Hay THE RESPIRATORY VIRUSES: INFLUENZA, RSV, AND RHINOVIRUSES Introduction: Respiratory viruses are among the most common causes of symptomatic human infections.
HUMAN PAPILLOMAVIRUS INFECTION AND CERVICAL …
www.formatex.orgHUMAN PAPILLOMAVIRUS INFECTION AND CERVICAL CANCER: PATHOGENESIS AND EPIDEMIOLOGY Daniel Tena Gómez1∗ and Juana López Santos2. 1Section of Microbiology.2Service of Clinical Analysis.University Hospital of Guadalajara. C/. Donante
Interpretation and Action Needed HBsAg HBsAb HBcAb
www.hepb.orgUn d erstan d i n g Y o u r Hep ati ti s B Bl o o d T ests Understanding your hepatitis B blood test results can be confusing. It is important to talk to your doctor so you understand
The Natural History of Hepatitis C Virus (HCV) Infection
www.medsci.orgInt. J. Med. Sci. 2006, 3 48 In the transfusion setting, where acute onset of HCV infection has been best documented, 70% to 80% of cases were asymptomatic.[14]